Mitsubishi Chemical has given Bain first refusal right to negotiate purchase of subsidiary, Nikkei says

TOKYO : Mitsubishi Chemical Group has given the U.S. investment fund Bain Capital the right of first refusal to negotiate the purchase of its pharmaceutical subsidiary, Tanabe Mitsubishi Pharma, the Nikkei reported on Monday.

Mitsubishi Chemical is likely to sell Tanabe Mitsubishi Pharma to Bain Capital for more than 500 billion yen, the report said..